Your browser doesn't support javascript.
loading
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
Zhang, Fengwen; Schmidt, Fabian; Muecksch, Frauke; Wang, Zijun; Gazumyan, Anna; Nussenzweig, Michel C; Gaebler, Christian; Caskey, Marina; Hatziioannou, Theodora; Bieniasz, Paul D.
Afiliación
  • Zhang F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Schmidt F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Muecksch F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Wang Z; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Gazumyan A; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Nussenzweig MC; Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.
  • Gaebler C; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Caskey M; Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.
  • Hatziioannou T; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Bieniasz PD; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
mBio ; 15(2): e0167223, 2024 Feb 14.
Article en En | MEDLINE | ID: mdl-38193662
ABSTRACT
The glycosylation of viral envelope proteins can play important roles in virus biology and immune evasion. The spike (S) glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) includes 22 N-linked glycosylation sequons and 17 O-linked glycosites. We investigated the effect of individual glycosylation sites on SARS-CoV-2 S function in pseudotyped virus infection assays and on sensitivity to monoclonal and polyclonal neutralizing antibodies. In most cases, the removal of individual glycosylation sites decreased the infectiousness of the pseudotyped virus. For glycosylation mutants in the N-terminal domain and the receptor-binding domain (RBD), reduction in pseudotype infectivity was predicted by a commensurate reduction in the level of virion-incorporated S protein and reduced S trafficking to the cell surface. Notably, the presence of a glycan at position N343 within the RBD had diverse effects on neutralization by RBD-specific monoclonal antibodies cloned from convalescent individuals. The N343 glycan reduced the overall sensitivity to polyclonal antibodies in plasma from COVID-19 convalescent individuals, suggesting a role for SARS-CoV-2 S glycosylation in immune evasion. However, vaccination of convalescent individuals produced neutralizing activity that was resilient to the inhibitory effect of the N343 glycan.IMPORTANCEThe attachment of glycans to the spike proteins of viruses during their synthesis and movement through the secretory pathway can affect their properties. This study shows that the glycans attached to the severe acute respiratory syndrome coronavirus-2 spike protein enable its movement to the cell surface and incorporation into virus particles. Certain glycans, including one that is attached to asparagine 343 in the receptor-binding domain of the spike protein, can also affect virus neutralization by antibodies. This glycan can increase or decrease sensitivity to individual antibodies, likely through direct effects on antibody epitopes and modulation of spike conformation. However, the overall effect of the glycan in the context of the polyclonal mixture of antibodies in convalescent serum is to reduce neutralization sensitivity. Overall, this study highlights the complex effects of glycosylation on spike protein function and immune evasion.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: MBio Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: MBio Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos